Skip to content
sellNotable cluster of 4

David L Mahoney sold $1.7M of CORT

director at CORCEPT THERAPEUTICS INC. 20,000 shares at an average of $84.53, traded Jun 17, 2026, filed Jun 18, 2026.

Warning score
65
Value
$1.7M
20,000 shares
Holdings after
26,147
-43% from before
From 52-week low
+154%
low $32.15, close $81.75
From 52-week high
-9%
high $90.32, as of Jun 17, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $1.7M at market
    +25
  • Share of holdings sold
    Sold 43% of holdings
    +10
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CORTOct 12, 2026 · close 121.19
Since filing Jun 18, 2026: +51.7%SPY +4.4% · excess +47.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001193125-26-275963, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 17, 2026SOpen-market sale
Common Stockindirect: The Black Dog Private Foundation
-20,000$84.53$1.7M26,147Jun 18, 2026

Related signals

Other insiders at CORCEPT THERAPEUTICS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
40Moderate
CORTsell 310b5-1
CORCEPT THERAPEUTICS INC
Sean Maduck
See Remarks
$2.9M
25,000 shares
-242%
40Moderate
CORTsell 310b5-1
CORCEPT THERAPEUTICS INC
Joseph Douglas Lyon
See Remarks
$1.2M
10,000 shares
-154%
45Moderate
CORTsell 310b5-1
CORCEPT THERAPEUTICS INC
Roberto Wandenkolk Vieira
President, Oncology
$967k
8,333 shares
-68%
20Weak
CORTsell 310b5-1
CORCEPT THERAPEUTICS INC
Roberto Wandenkolk Vieira
President, Oncology
$30k
296 shares
-7%
35Weak
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
James N Wilson
director
$1.1M
10,000 shares
-1%
40Moderate
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
Joseph Douglas Lyon
See Remarks
$1.1M
10,000 shares
-64%
45Moderate
CORTsell 510b5-1
CORCEPT THERAPEUTICS INC
Roberto Wandenkolk Vieira
President, Oncology
$6.5M
58,333 shares
-93%
40Moderate
CORTsell 610b5-1
CORCEPT THERAPEUTICS INC
Sean Maduck
See Remarks
$2.9M
25,000 shares
-72%
60Notable
CORTsell 6
CORCEPT THERAPEUTICS INC
Kimberly Park
director
$3.3M
26,685 shares
-100%
40Moderate
CORTsell 610b5-1
CORCEPT THERAPEUTICS INC
Sean Maduck
See Remarks
$3.9M
30,955 shares
-76%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David L Mahoney sold $1.7M of CORT | InsiderTell